Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
98 USD | -0,01% | -2,00% | -2,00% |
Omzet 2024 * | 49,05 mld. 45,17 mld. | Omzet 2025 * | 51,11 mld. 47,08 mld. | Marktkapitalisatie | 203 mld. 187 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 10,48 mld. 9,65 mld. | Nettowinst (verlies) 2025 * | 11,74 mld. 10,81 mld. | EV/omzet 2024 * | 4,39 x |
Nettoschuld 2024 * | 12,07 mld. 11,11 mld. | Nettoschuld 2025 * | 10,61 mld. 9,77 mld. | EV/omzet 2025 * | 4,19 x |
K/w-verhouding 2024 * |
18,8
x | K/w-verhouding 2025 * |
16,3
x | Werknemers | 76.057 |
Dividendrendement 2024 * |
3,58% | Dividendrendement 2025 * |
3,72% | Vrij verhandelbaar | 85,22% |
Recentste transcriptie over Novartis AG
1 dag | -0,01% | ||
1 week | -2,00% | ||
Lopende maand | +1,03% | ||
1 maand | +1,03% | ||
3 maanden | -3,07% | ||
6 maanden | +1,53% | ||
Lopend jaar | -2,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 01-01-05 | |
Director of Finance/CFO | 59 | 01-01-03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16-05-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01-01-13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28-02-20 |
Chairman | 68 | 01-01-13 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-05-24 | 98 | -0,01% | 153 |
23-05-24 | 98,01 | -4,84% | 1 339 |
22-05-24 | 103 | +3,00% | 425 |
21-05-24 | 100 | +1,95% | 310 |
uitgestelde koers OTC Markets, 28 mei 2024 om 17:49 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,43% | 727 mld. | |
-7,86% | 354 mld. | |
+15,59% | 328 mld. | |
-0,48% | 277 mld. | |
+13,47% | 243 mld. | |
-6,42% | 203 mld. | |
+3,62% | 164 mld. | |
-2,10% | 164 mld. | |
-1,31% | 122 mld. |
- Beurs
- Aandelen
- Koers NOVN
- Koers NVSEF